Hallucinations and Other Psychotic Symptoms Associated With the Use of Attention-Deficit/Hyperactivity Disorder Drugs in Children

@article{Mosholder2009HallucinationsAO,
  title={Hallucinations and Other Psychotic Symptoms Associated With the Use of Attention-Deficit/Hyperactivity Disorder Drugs in Children},
  author={Andrew D Mosholder and Kate Gelperin and Tarek A. Hammad and Kathleen M. Phelan and Rosemary Johann-Liang},
  journal={Pediatrics},
  year={2009},
  volume={123},
  pages={611 - 616}
}
OBJECTIVES. To gain a better understanding of the capacity of psychostimulant medications to induce adverse psychiatric reactions and determine the frequency of such reactions, we analyzed postmarketing surveillance data and clinical trial data for drugs, either approved or under development, for the treatment of attention-deficit/hyperactivity disorder. METHODS. The US Food and Drug Administration requested manufacturers of drugs approved for attention-deficit/hyperactivity disorder or with… Expand
PSYCHOTIC SYMPTOMS DURING STIMULANT TREATMENT FOR ATTENTION-DEFICIT/HYPERACTIVITY DISORDER
Introduction: Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental disorder. Pharmacological treatment, either alone or in combination with psychosocial interventions, isExpand
Syddansk Universitet Hallucinations and other psychotic symptoms in response to methylphenidate in children and adolescents with attention-deficit / hyperactivity disorder
Background: There is little evidence in the literature on the association between methylphenidate treatment and psychotic symptoms in children and adolescents with attention-deficit/hyperactivityExpand
Psychosis with Methylphenidate or Amphetamine in Patients with ADHD
TLDR
Among adolescents and young adults with ADHD who were receiving prescription stimulants, new‐onset psychosis occurred in approximately 1 in 660 patients, and Amphetamine use was associated with a greater risk of psychosis than methylphenidate. Expand
Hallucinations and other psychotic symptoms in response to methylphenidate in children and adolescents with attention-deficit/hyperactivity disorder: a Cochrane systematic review with meta-analysis and trial sequential analysis#
TLDR
It is unable to confirm or refute whether methylphenidate increases the risk of psychotic symptoms in children and adolescents with ADHD, but physicians, patients and caregivers should be aware of this to ensure proper treatment in case of occurrence duringmethylphenidate treatment. Expand
Methylphenidate for psychosis and aggression in a patient comorbid with ADHD - A case report.
TLDR
While caring for a patient with comorbidity of ADHS and psychosis the authors were not able to find guidelines or treatment recommendations issued by a major society concerning state of the art treatment of such a case. Expand
Parental Reporting of Adverse Drug Reactions Associated with Attention-Deficit Hyperactivity Disorder (ADHD) Medications in Children Attending Specialist Paediatric Clinics in the UK
TLDR
The results of this study demonstrate the feasibility of using specialist clinics to target both at-risk patient populations and/or medicines of interest, using specialist medical clinics and the practicality and feasibility of parental reporting. Expand
Methylphenidate and the risk of psychotic disorders and hallucinations in children and adolescents in a large health system
TLDR
This study does not support the hypothesis that MPH increases risk of incident psychotic events, but indicates an increased risk of psychotic events before the first prescription of MPH, which may be because of an association between psychotic events and the behavioural and attentional symptoms that led to psychiatric assessment and initiation of MPH treatment. Expand
Stimulant treatment effectiveness, safety and risk for psychosis in individuals with 22q11.2 deletion syndrome
TLDR
Preliminary long-term retrospective analysis suggests that stimulant treatment in 22q11.2DS is apparently safe in terms of psychosis conversion and rates of side effects, and that it is effective in alleviating ADHD symptoms. Expand
Stimulant Medication and Psychotic Symptoms in Offspring of Parents With Mental Illness
TLDR
A temporal relationship between use of stimulants and psychotic symptoms was supported by an association between current stimulant use and current psychotic symptoms and co-occurrence in cases that were assessed on and off stimulants. Expand
Safety of Psychotropic Drugs in Children and Adolescents
TLDR
Additional safety data are urgently needed to clarify the risk-benefit ratio of psychotropic medications in children and adolescents and to adequately guide medical decision-making. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 25 REFERENCES
Adderall-induced psychosis in an adolescent.
TLDR
To date, there have been no published reports of psychotic reactions to amphetamine (Adderall) in an adolescent patient, and a search of MEDLINE and pre-MEDLINE using keywords including “ Adderall,” “ methamphetamine,’ “dextroamphetamine,�” and “psychosis” found no reports. Expand
Hallucinations during methylphenidate therapy
TLDR
The causal role of MPH in the development of hallucinations was based on their appearance after ingestion of the drug, resolving after its withdrawal, and the absence of psychiatric comorbidity that could explain such phenomena. Expand
Psychotic and manic-like symptoms during stimulant treatment of attention deficit hyperactivity disorder.
  • R. Ross
  • Medicine, Psychology
  • The American journal of psychiatry
  • 2006
A boy 6 years 9 months of age was brought by his mother to a child psychiatrist for difficulties with sustained attention, distraction, careless errors, poor listening, difficulty followingExpand
Psychotic Side Effects of Psychostimulants: A 5-Year Review
TLDR
awareness of the potential for psychotic side effects from stimulant medications is important when prescribing for children and a large prospective study would be useful to predict the frequency and classification of the side effects in children. Expand
Mental health in the United States. Prevalence of diagnosis and medication treatment for attention-deficit/hyperactivity disorder--United States, 2003.
  • Medicine
  • MMWR. Morbidity and mortality weekly report
  • 2005
TLDR
To estimate rates of parent-reported ADHD diagnosis and medication treatment for ADHD, CDC analyzed data from the 2003 National Survey of Children's Health (NSCH), which indicated that, in 2003, approximately 4.4 million children aged 4-17 years were reported to have a history of ADHD; of these, 2.5 million (56%) were reporting to be taking medication for the disorder. Expand
Abuse and toxicity of methylphenidate.
TLDR
There is disagreement regarding the extent to which methylphenidate is being diverted from legitimate use to abuse in preteens and adolescents. Expand
Methylphenidate-induced delusional disorder in a child with attention deficit disorder with hyperactivity.
TLDR
A 6-year-old child with an Attention Deficit Disorder with Hyperactivity developed a florid psychotic disturbance in conjunction with methylphenidate therapy, suggesting that there is a spectrum of stimulant-induced psychoses in children that parallels well-known signs of stimulants intoxication in general. Expand
Dopamine in schizophrenia: a review and reconceptualization.
TLDR
The authors hypothesize that schizophrenia is characterized by abnormally low prefrontal dopamine activity leading to excessive dopamine activity in mesolimbic dopamine neurons (causing positive symptoms) and has important implications for treatment of schizophrenia and schizophrenia spectrum disorders. Expand
Methylphenidate-induced hallucinosis: case histories and possible mechanisms of action.
ABSTRACT Published reports of toxic hallucinosis during treatment with methylphenidate are rare. Two cases are described, and it is suggested that methylphenidate-induced hallucinosis is more commonExpand
Methylphenidate‐Induced Hallucinosis: Case Histories and Possible Mechanisms of Action
  • J. Young
  • Medicine
  • Journal of developmental and behavioral pediatrics : JDBP
  • 1981
TLDR
It is suggested that methylphenidate-induced hallucinosis is more common than has been appreciated and two other hypotheses that may clarify underlying mechanisms of action that produce toxic effects relate to (1) noradrenergic facilitation of transmission of information in the visual pathway, and (2) interactions among brain monoamine systems. Expand
...
1
2
3
...